$ABVC Phase IIb Clinical Plan Initiated April 2023, expected to be completed during Q4 2024 From Oct. 22 PR - ABVC has received 23M AiBtl shares as part of the first milestone of the licensing fees and will obtain royalties up to $100M after the product launches.
no approved reverse split
the company is on 1st 180 day extension has until January 6, 2025, to regain compliance
lowest warrants at $1
from ER on 14/08 - ''Vitargus has started the construction of a GMP factory in Hsinchu Biomedical Science Park, Taiwan, with the aim at building a production base to supply the global market, and promote the construction of bio-degradable vitreous substitute manufacturing centers in Taiwan. Completion of this factory would allow ABVC to manufacture Vitargus with world-class technology in a GMP certified pharmaceutical factory. BioFirst is targeting to complete the construction in 2024.''

and more from PR on 22/10 - ''...The payment, tied to ABVC's psychiatric disorder pipeline, which includes treatments for Major Depressive Disorder (MDD) and Attention Deficit Hyperactivity Disorder (ADHD), is part of a broader agreement with AiBtl BioPharma. The MDD and ADHD pipeline, valued at $667M by third-party evaluators, continues to gain momentum as both companies advance their collaborative efforts towards discussion with big pharma for out-licensing and initiating the plan for the GAP-certified temperature-controlled farm. ''

Took some $SNOA for a swing

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
The new eye care line will also feature refreshed design and improved packaging for Ocucyn® Eyelid & Eyelash Cleanser. The full line will be introduced at the American Academy of Ophthalmology's annual meeting in Chicago, October 18-21, 2024

https://www.accesswire.com/915832/sonoma-pharmaceuticals-and-emc-pharma-announce-collaboration-to-co-market-an-expanded-eye-care-product-line

big catalyst coming up for this low floater
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference taking place September 27-30, 2024
https://ir.nuwellis.com/news-releases/news-release-details/new-evidence-aquadex-ultrafiltration-therapy-be-presented-hfsa

KVHI $1.55m form 4

$SGE 1.7m float and they have 55 months of cash, Insiders own 78.29% and there is no dilution at all. the short shares available sits at just 30k with very high cost to borrow of 403% , company has entered into a merger agreement with Fundamental Global Inc in a deal of $30 million valuation so that's valued at 3X current MC (11m) it is expected to close any day now (mid-2024)

"We also received a second critical oil & gas system order with our partners at NESR in the Middle East. This order is scheduled to be delivered in June of this year and will be a key contributor to the positive sequential growth that we expect in the second quarter."

$BCDA catalysts;
''Our planned Morph-DNA submission to the FDA for approval of a product family from 5 French to 8 French diameters is on track for submission in the second quarter of 2024''
''Q2: Enrollment in the CardiAMP Cell Therapy Heart Failure Trial''
''Q2: Completion of low dose cohort''
''Q2: Third revenue sharing partnership agreement''

Forza X1 $FRZA float is only 8m for a 30c name and company has 22 months of cash on hand , has no dilution at all , Insiders own 45% also They anticipate starting sales of their electric boats in Q2, generating their first revenue from powertrain, and delivering to customers during the same quarter.

$FRZA catalysts; The company expects to begin selling their F22 monohull electric boats by Q2 2024 Forza X1 anticipates generating its first revenue from the powertrain in Q2 2024 They plan to start customer deliveries in Q2 2024

has a 1m float with only 2.6m market cap and chart just above 52wk lows Company also has 4 new products that they are planning on rolling out this month plus zero short shares available right now with 222% cost to borrow

$BSFC catalyst - '' We also intend to rollout of 4 new products at the club store segment, commencing in late June, 2024 ''

Took $NKGN for a swing low float bottom bio with a catalyst coming in a few days and no way to dilute right now, great consolidating chart with very low short shares available - 7K and cost to borrow at - 347% , this name also has done big moves recently as well.

$NKGN 01/06/2024 ET - Phase 1 interim data to be presented at ASCO on June 1, 2024

pennies are the hottest theme right now and this one has 3 fresh 13G filings of 10% each totaling 30% and a market cap of approx 300K which is crazy low with $12.8m cash on hand and only a 12m float, warrants have an exercise price of $0.85 and cash/sh is currently $1.00 chart also has a gap at $1.10

$CETX 3 new 13G's;
2024-05-13 - 9.99%
2024-05-10 - 9.99%
2024-05-08 - 9.99%

Took $LUMO for a swing bottom bio has 5.7m float , 9.9 months of cash and no dilution at all. Had a Patent PR today that went unnoticed and also 2 near term catalysts as well, Institutions own 44.97% of the Float and Insiders own 35% , Had 13G filing on February of 5.30% with recently released price target of $28

LUMO Catalyst #1 - Friday May 3rd , 2024 - ''end of Phase 2 meeting planned for May 3, 2024''

LUMO Catalyst #2 - Sunday May 12th , 2024 - ''Phase 2 data to be presented at the European Congress of Endocrinology (ECE) on May 12, 2024''

$LUMO announced a patent today May 1st , 2024 - ''LUMOS PHARMA, INC has been assigned a patent (No. US 11969416 B1, initially filed Nov. 22, 2022 )
for "Compactable oral formulations of ibutamoren."

RNAZ pennies getting flow and this one has catalyst;
Phase 1 trials expected to commence any day now ( Q2 2024 )
same price range as ACON and known runner

company announced Cancellation of offering a week ago and price did not recover yet they also have no other dilution on filing. float is 3.85m , mkt cap 7.9m , Cash/sh $10.56 , book/sh $3.917 with 128m Assets , 22m Q rev and 83m cash on hand with Positive cash flow. chart has a nice gap to fill at $2.06

$VISL video, AI and drone communication play with great consolidating bottom chart and catalyst this week and later this month. Company has drone tech that can be utilized in the current Iran/Israel conflict as well. I took a position here at $3.58, Float is 2.45m , mktcap 8m , no dilution at all and company has 14 months of cash left, Book/sh $15 , Cash/sh $4.12 Assets 45m with 0 debt

$VISL Catalyst: The Company's Smallest-Ever Transmitter DragonFly V will Debut at NAB 2024 Apr 13, 2024 – Wed, Apr 17, 2024

Also: On April 27th, Vislink Technologies will be instrumental in providing the technology for the live transmission of footage from the A2RL (Abu Dhabi Autonomous Racing League) series event at the Yas Marina Circuit

VISL drone tech can be vital in ongoing Israel/Iran conflict;
''with the opportunity to leverage the Company's proprietary hardware infrastructure and Air-to-Anywhere software solution platform. The company is Continuing to build an international sales pipeline in the middle east''

Phase 2 data due at AAN 2024 on April 14, 2024.

INKT for swing Preclinical data is to be shared at AACR on April 8, 2024
Float 5m Insiders own 71.34% , had 9.68% 13D from 14/02/24 , No dilution

$MGOL MGO Global Expects to Report a 400% + Increase in Total Revenues for Full Year 2023 on April 1, 2024

also has this 8-K filing from March 26 still no PR (might get that as soon as Monday):

On March 20, 2024, MGO Global Inc. reached an agreement with Centric Brands LLC to transfer the Trademark License Agreement of the Messi Store, involving a $2,000,000 payment. The deal was formalized through a Deed on March 21, 2024. By March 30, 2024, Centric will assume control of The Messi Store, relieving MGO Global Inc. of payment obligations and streamlining operations.

$HPCO fresh r/s cannabis theme float 1.12m has cash and warrants at $15 had news on friday as well

''Hempacco Secures $250K Purchase Order from WARPD Labs for Exclusive Product Line of Gummies, Vapes, and Hemp Pre-Rolls'' pic.twitter.com/qtxTAYcile

— STOCKS Gambino (@StocksGambino) March 18, 2024

$GTBP recent r/s Bio 1.34m float with 15 months of cash $8.52 cash/sh and no dilution has large pipeline and recently submitted IND application pic.twitter.com/icI6E2OapY

— STOCKS Gambino (@StocksGambino) March 12, 2024

$GXAI fresh r/s with no dilution and 11 months of cash 780k float
Can run after $PIK $AUUD pic.twitter.com/UdYlSn9Fgx

— STOCKS Gambino (@StocksGambino) March 11, 2024

$TGL bottom ai name recent r/s 1m float no dilution and has cash ceo bought $98k early Feb with good ER as well
also had couple 13G filings and recent ai news pic.twitter.com/iTtj6icwxn

— STOCKS Gambino (@StocksGambino) March 7, 2024

$IFBD fresh china r/s name can move after $DTSS
850k float with 124 months of cash and Convertible Notes at $10 pic.twitter.com/klt4Kx6lzL

— STOCKS Gambino (@StocksGambino) March 5, 2024

$PBM beat up despac bio pic.twitter.com/i7y4nnYBCw

— STOCKS Gambino (@StocksGambino) March 4, 2024

$LIPO Bio with nice bottom chart 6.6m float, 10 months of cash Insiders own 36% Warrants at $1.40 last offering was at $1.52 and has Upcoming catalyst pic.twitter.com/2j5I3G9MTE

— STOCKS Gambino (@StocksGambino) March 4, 2024

$GOVX bottom bio recent r/s 2.48M float with $3.54 cash per share and warrants at $6.21 CEO and CFO bought at these levels this month + 13G of 9.99% from 14/02/24

''GeoVax to Present at the 2024 BIO CEO & Investor Conference at February 26, 2024, 4:15 pm ET'' pic.twitter.com/8sXy5x4gpa

— STOCKS Gambino (@StocksGambino) February 26, 2024

$FRGT $2.12 --> $3.83

Nice 80% run on this swing from morning pr:
''Fr8App Secures Strategic Routes with Envases Universales for Logistics Services, Valued at More Than $5 Million Dollars'' https://t.co/LFDEmUVVcx

— STOCKS Gambino (@StocksGambino) February 26, 2024

$ELAB bottom chart 1.8M float no dilution and 6.6 months of cash with 22.07% 13D out today, only 20k short shares left pic.twitter.com/EFsfxgkXqv

— STOCKS Gambino (@StocksGambino) February 21, 2024

$JXJT Hit 3.84 this AM 70% move overnight https://t.co/OLJkzchE52

— STOCKS Gambino (@StocksGambino) February 21, 2024

$JXJT recent china runner 5m float with 0 short shares pic.twitter.com/G59MhaMG8A

— STOCKS Gambino (@StocksGambino) February 20, 2024

$FRGT bottom chart 2.4m float ai theme getting hot pic.twitter.com/JWrf6gDod3

— STOCKS Gambino (@StocksGambino) February 16, 2024

bullish

$PCSA Bottom chart 2.6M float Offering closed yesterday
Recent r/s name with 3 Insider buys this week and upcoming catalyst pic.twitter.com/QZjt346W0f

— STOCKS Gambino (@StocksGambino) February 2, 2024

$POL like this one as $NEXI symp play
317% CTB & only 70k short shares available
Warrants at $12 Meeting of Stockholders today to cure non-compliance. 2M float with 346 months of cash

had news today as wellhttps://t.co/E7sFChGYWL

— STOCKS Gambino (@StocksGambino) January 30, 2024

$CUTR nice chart with 12 months of cash, institutional ownership at 75% and no dilution coming off bottom with 9% 13G on 01/19/24
insiders bought at $9 pic.twitter.com/OjEo11wX40

— STOCKS Gambino (@StocksGambino) January 25, 2024

$MGRX PR with @barstoolsports coming very soon and New product launch end of month
Has warrants at $1 CEO added 1.5M shares recently pic.twitter.com/povvTR462I

— STOCKS Gambino (@StocksGambino) January 18, 2024

$WKEY Low float with no dilution and a great looking chart

"will be participating at the CES 2024 which will be taking place from January 9-12 in Las Vegas, NV." pic.twitter.com/L0KRch1anS

— STOCKS Gambino (@StocksGambino) January 8, 2024

$ADIL another small bio getting attention now pic.twitter.com/oCNyRr81Tj

— STOCKS Gambino (@StocksGambino) December 29, 2023

$SXTP 19.9% 13Ghttps://t.co/2TGdN884FX pic.twitter.com/5Lizh4wZKG

— STOCKS Gambino (@StocksGambino) December 18, 2023

$LGMK ''New PERS Device Expected to Launch in Fourth Quarter'' pic.twitter.com/GNyHb7f9wh

— STOCKS Gambino (@StocksGambino) December 7, 2023

''Heliogen Transitions to Testing, Secures Contract and Award.''
$HLGN
a leading provider of AI-enabled concentrating solar energy technology
Selected to receive an additional $4.1 million award from the DOE
Mkt cap - 47M
Share Price - 0.245c
cash per share - 0.80c
book value per share - 0.80c
cash - $121.9 MILLION (remember mkt cap Is 47M lmao)
Insiders buying at 0.21c-0.25c as of latest form 4 and 13A

Recent Highlights
•Completed the preliminary design and secured a site for the “Proxima” green hydrogen project in Lancaster, CA
•Achieved successful accumulation of over 125 hours of operational life and 25 miles travelled on the ChariotAV, Heliogen’s autonomous cleaning vehicle
•Following the leadership transition of Heliogen’s CEO in February 2023, announced Strategic Plan and formed Board-level Corporate Strategy Committee to oversee the implementation of Heliogen’s long-range strategic plan and specific strategic initiatives